
In a significant win for independent pharmacies, Health Law Alliance has secured the dismissal of a lawsuit filed by Cardinal Health, Inc. (Cardinal), a multinational corporation, against our clients, several independent pharmacies and pharmacy owners located in Texas, New Jersey, and New York. The United States District Court for the Southern District of Ohio granted dismissal of Cardinal’s amended complaint pursuant to Rule 41(a)(2) of the Federal Rules of Civil Procedure.
The dismissal comes after Health Law Alliance filed a comprehensive motion to dismiss, challenging the merits of Cardinal's case. Our motion argued that the Court lacked personal jurisdiction over the defendants, that Cardinal had failed to state a valid claim for relief, and that the defendants were improperly joined together in a single lawsuit.
Cardinal filed its original complaint last December in state court in Ohio, positing baseless allegations of breach of contract, fraudulent inducement, and conspiracy by Defendants, arising out of their Independent Pharmacy Returns Program. After the case was removed to federal court, Health Law Alliance moved to dismiss the complaint. After numerous stalling attempts to stave off dismissal of its baseless action, Cardinal finally voluntarily consented to dismissal of its complaint by the Court.

This lawsuit represents a classic example of a large corporation attempting to leverage its size and resources to intimidate and extract profits from smaller, independent pharmacies. Cardinal Health, headquartered in Dublin, Ohio, engaged in blatant forum shopping, filing the lawsuit in its home state in an attempt to gain an unfair advantage. This calculated move was designed to inconvenience and financially strain the defendants, who are located hundreds of miles away, in the hopes of forcing a quick settlement and boosting their shareholder value. Cardinal’s complaint attempted to lump together a disparate group of defendants in a baseless legal action. Our attorneys meticulously dismantled Cardinal Health's arguments, exposing the complaint's deficiencies and the plaintiff's transparent attempt to manipulate the legal system.
The voluntary dismissal by Cardinal Health after our motion to dismiss was filed speaks volumes. It is a tacit admission of the weakness of their case and a victory for every independent pharmacy that has been targeted by the predatory tactics of pharmaceutical wholesalers.
This outcome is not just a win for our clients; it is a testament to the principle that justice is not determined by the size of a litigant's bank account. Health Law Alliance remains steadfast in its commitment to defending the rights of healthcare providers and suppliers against the overreach of powerful corporations and government agencies. We are proud to have delivered this result for our clients, and will continue to fight to ensure a level playing field for businesses in the healthcare industry.
MORE ARTICLES BY CATEGORY
Ketamine Clinics & Compounders Now the Focus of Increased DEA Enforcement
The DEA is increasingly targeting ketamine providers with record-keeping inspections and audits, making expert Medicare and DEA compliance defense essential to avoid steep fines and license risks.
Read More >>HLA's Diana Yastrovskaya Featured on Live TV for PBM Expertise
The feature underscores HLA’s mission to elevate thought leadership within the healthcare space and provide trusted expertise on issues that directly impact patients, providers, and policymakers.
Read More >>By Appointment Only: How DME Suppliers Can Prevent Unexpected DME License Revocations
DME suppliers can prevent unexpected and costly license revocations by strategically applying with a "By Appointment Only" designation. This article explores the common compliance trap of failing unannounced site visits due to conflicts between standard pharmacy operating hours and Medicare's "posted hours" requirement for DME suppliers. "By Appointment Only" status is a crucial safeguard, which suppliers can take to implement to protect their DME billing privileges.
Read More >>Resolving Prescription “Red Flags” Is No Longer Optional: Federal Scrutiny Tightens on Controlled-Substance Dispensing
Pharmacists must resolve “red flags” under the Controlled Substances Act’s corresponding-responsibility requirements before dispensing controlled substances. Overlooking warning signs, such as cash-paid, high-dose opioid prescriptions—can now trigger False Claims Act liability and massive penalties, as demonstrated by Walgreens’ $350 million settlement in April 2025.
Read More >>